VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2016 | EURO-SKI trial: stopping tyrosine kinase inhibitors in a very large cohort of European CML patients

Press brief by Johan Richter, MD, PhD of the Skåne University Hospital Lund, Lund, Sweden, at the 2016 Annual Meeting of the European Association of Hematology (EHA), held in Copenhagen, Denmark.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter